| __timestamp | Protagonist Therapeutics, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1860000 | 72471000 |
| Thursday, January 1, 2015 | 2963000 | 89204000 |
| Friday, January 1, 2016 | 6961000 | 106010000 |
| Sunday, January 1, 2017 | 11779000 | 137905000 |
| Monday, January 1, 2018 | 13697000 | 159888000 |
| Tuesday, January 1, 2019 | 15749000 | 158425000 |
| Wednesday, January 1, 2020 | 18638000 | 200677000 |
| Friday, January 1, 2021 | 27196000 | 304759000 |
| Saturday, January 1, 2022 | 31739000 | 377221000 |
| Sunday, January 1, 2023 | 33491000 | 336361000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biopharmaceuticals, effective cost management is crucial. Protagonist Therapeutics, Inc. and Supernus Pharmaceuticals, Inc. offer a compelling study in contrasts over the past decade. From 2014 to 2023, Protagonist Therapeutics saw its Selling, General, and Administrative (SG&A) expenses grow by an impressive 1,700%, reflecting its aggressive expansion and strategic investments. Meanwhile, Supernus Pharmaceuticals, with a more established market presence, experienced a 360% increase in SG&A expenses, indicating steady growth and sustained market operations.
By 2023, Supernus Pharmaceuticals' SG&A expenses were nearly ten times those of Protagonist Therapeutics, highlighting its larger scale and broader market reach. This data underscores the diverse strategies employed by these companies in managing operational costs, offering valuable insights for investors and industry analysts alike.
Who Optimizes SG&A Costs Better? GSK plc or Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing argenx SE and Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Verona Pharma plc and Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Supernus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.